Akshay Flora

Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study

Emily Kozera, Akshay Flora, John W. Frew · Journal of the American Academy of Dermatology · 2022 · 52 citations

Retrospective Cohort Study, Medicine, Clinical Dermatology +6

A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativa

Rebecca Jepsen, Chloe Edwards, Akshay Flora et al. · Journal of the American Academy of Dermatology · 2023 · 31 citations

Autoimmune Disease, Moderate-to-severe Hidradenitis Suppurativa, Pathology +5

Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study

Akshay Flora, Emily Kozera, John W. Frew · Journal of the American Academy of Dermatology · 2023 · 23 citations · Full text

Retrospective Cohort Study, Pharmacology, Clinical Dermatology +5

Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with Malassezia-specific immunoglobulin E levels mirroring clinical response

Emily Kozera, Akshay Flora, T. D. Stewart et al. · Journal of the American Academy of Dermatology · 2022 · 20 citations

Autoimmune Disease, Medicine, Immunology +9

Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)

Akshay Flora, Richard Holland, Annika Smith et al. · JAAD Case Reports · 2021 · 15 citations · Full text

Il-23p19 Antagonist, Immunology, Pathology +17